Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1Michio Sata, Teruko Hino-Arinaga, Tatsuya Ide et al.|Journal of Gastroenterology|2011Cited by 42
An analysis of drug-induced liver injury, which showed histological findings similar to autoimmune hepatitisAkiko Hisamochi, Takuji Torimura, Kei Ogata et al.|Journal of Gastroenterology|2015Cited by 38
Metronomic S-1 Chemotherapy and Vandetanib: An Efficacious and Nontoxic Treatment for Hepatocellular CarcinomaHideki Iwamoto, Michio Sata, Takuji Torimura et al.|Neoplasia|2011Cited by 32
Metabolic management after sustained virologic response in elderly patients with hepatitis C virus: A multicenter studyTomoya Sano, Keisuke Amano, Tatsuya Ide et al.|Hepatology Research|2023Cited by 23
Growth differentiation factor 15 as a novel diagnostic and therapeutic marker for autoimmune hepatitisTeruko Arinaga‐Hino, Takuji Torimura, Tatsuya Ide et al.|Scientific Reports|2022Cited by 16